Categories: Wire Stories

Mitsubishi Electric, Okayama University, and Osaka University Develop Magnetic Particle Imaging Device Capable of Producing Images of Human Brain

The world’s first high-sensitivity imaging device capable of operating at low frequencies with compact power supply, will facilitate diagnosis of pre-Alzheimer’s

TOKYO–(BUSINESS WIRE)–Mitsubishi Electric Corporation (TOKYO: 6503), Okayama University and Osaka University’s Graduate School of Engineering announced today that they have developed a magnetic particle imaging device capable of sensitive imaging of magnetic particles in an area equivalent in size to that of the human brain, in a project supported by the Japan Agency for Medical Research and Development (AMED). The device operates at low frequencies of 1 kHz or less, a world-first, allowing the use of a significantly smaller power supply unit. The utilization of this device to image magnetic particles that bind to amyloid-β, the causative agent of Alzheimer’s, will allow the accumulation and distribution of amyloid-β to be quantified. The aim is to allow imaging-based assessments of the likelihood of Alzheimer’s developing prior to the onset of the disease.


The number of dementia patients aged 65 and older in Japan is expected to reach 7 million in 2025. Significant statistical findingsindicate that Alzheimer’s accounts for 67.6% of these dementia cases. In June of this year, Japan enacted the Dementia Basic Law, aimed at advancing dementia prevention efforts. In August, a panel of experts from Japan’s Ministry of Health, Labour and Welfare gave a green light for the manufacture and sale of a drug that targets the accumulation of amyloid-β in the brain, a potential factor in the development of Alzheimer’s, thereby inhibiting the progression of the disease. Initiating medication early during a phase of low amyloid-β accumulation in the brain has been shown to help suppress the onset of the disease. This underscores the necessity for technology capable of measuring both the accumulation and distribution of amyloid-β.

For the full text, please visit: www.MitsubishiElectric.com/news/

Contacts

Media Inquiries
Takeyoshi Komatsu

Public Relations Division

Mitsubishi Electric Corporation

Tel: +81-3-3218-2346

prd.gnews@nk.MitsubishiElectric.co.jp
www.MitsubishiElectric.com/news/

Alex

Recent Posts

Artistic Biomedical Limited Company Garners Two Accolades at the Asia Pacific Enterprise Awards 2024 Taiwan

SINGAPORE - Media OutReach Newswire - 6 November 2024 - Artistic Biomedical Limited Company took…

1 hour ago

Awesome Group Honored With Two Awards at the Asia Pacific Enterprise Awards 2024 Taiwan Chapter

SINGAPORE - Media OutReach Newswire - 6 November 2024 - Leading education & training brand,…

1 hour ago

Asia Responsible Enterprise Awards 2024 China Chapter Shines Light on ESG Champions Setting the Standard for Sustainability in Asia

SHANGHAI, CHINA - Media OutReach Newswire - 6 November 2024 - The Asia Responsible Enterprise…

2 hours ago

China Wantian Holdings was awarded the “2024 Hong Kong International ESG Award”

HONG KONG SAR – Media OutReach Newswire - 6 November 2024 - At the "2024…

4 hours ago

JustMarkets Gala Dinner 2024 — This Year’s Most Splendid and Rewarding Trading Event

KUALA LUMPUR, MALAYSIA - Media OutReach Newswire - 6 November 2024 - On the 28th…

5 hours ago

St. George’s University Emphasizes Pathology’s Critical Role in Advancing South Korea’s Healthcare Systems on World Pathology Day

SEOUL, SOUTH KOREA - Media OutReach Newswire - 6 November 2024 - On World Pathology…

6 hours ago